Ignite Creation Date:
2025-12-25 @ 3:46 AM
Ignite Modification Date:
2026-04-23 @ 8:50 PM
Study NCT ID:
NCT02062502
Status:
COMPLETED
Last Update Posted:
2018-10-30
First Post:
2014-02-12
Is NOT Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
Evaluation of Immunogenicity and Safety of VARIVAX™ New Seed Process (NSP) in Children (V210-063)
Sponsor:
Merck Sharp & Dohme LLC
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2014-03-07
Start Date Type:
ACTUAL
Primary Completion Date:
2015-02-24
Primary Completion Date Type:
ACTUAL
Completion Date:
2015-10-13
Completion Date Type:
ACTUAL
First Submit Date:
2014-02-12
First Submit QC Date:
None
Study First Post Date:
2014-02-13
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
2016-02-02
Results First Submit QC Date:
None
Results First Post Date:
2016-03-01
Results First Post Date Type:
ESTIMATED
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2018-10-01
Last Update Post Date:
2018-10-30
Last Update Post Date Type:
ACTUAL